WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007090068) CYANOISOQUINOLINE COMPOUNDS THAT STABILIZE HYPOXIA INDUCIBLE FACTOR (HIF)
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/090068    International Application No.:    PCT/US2007/061171
Publication Date: 09.08.2007 International Filing Date: 26.01.2007
IPC:
C07D 217/26 (2006.01), C07D 405/12 (2006.01), C07D 413/12 (2006.01), C07D 417/12 (2006.01), A61K 31/472 (2006.01), A61K 31/4725 (2006.01), A61P 7/06 (2006.01)
Applicants: FIBROGEN, INC. [US/US]; 225 Gateway Boulevard, South San Francisco, California 94080 (US) (For All Designated States Except US).
AREND, Michael, P. [DE/US]; (US) (For US Only).
FLIPPIN, Lee, A. [US/US]; (US) (For US Only).
WU, Min [CN/US]; (US) (For US Only).
TURTLE, Eric, D. [US/US]; (US) (For US Only).
HO, Wen-bin [US/US]; (US) (For US Only).
DENG, Shaojiang [CN/US]; (US) (For US Only)
Inventors: AREND, Michael, P.; (US).
FLIPPIN, Lee, A.; (US).
WU, Min; (US).
TURTLE, Eric, D.; (US).
HO, Wen-bin; (US).
DENG, Shaojiang; (US)
Agent: TANNER, Lorna, L.; Foley & Lardner LLP, 975 Page Mill Road, Palo Alto, California 94304-1013 (US)
Priority Data:
60/762,780 27.01.2006 US
Title (EN) CYANOISOQUINOLINE COMPOUNDS THAT STABILIZE HYPOXIA INDUCIBLE FACTOR (HIF)
(FR) COMPOSES DE CYANOISOQUINOLEINE ET PROCEDES D'UTILISATION DE CEUX-CI
Abstract: front page image
(EN)The present invention relates to cyanoisoquinoline compounds suitable for use in treating hypoxia inducible factor-mediated and/or erythropoietin-associated conditions. The cyanoisoquinoline compounds of the invention have the following structure: Formula (I).
(FR)La présente invention concerne des composés de cyanoisoquinoléine qui sont utilisables dans le traitement d'un facteur inductible par hypoxie et/ou de conditions liées à de l'érythropoïétine. Les composés de cyanoisoquinoléine de l'invention ont la structure suivante de formule (I).
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)